Opendata, web and dolomites

BioFlex SIGNED

Second life of wood: technology to dissolve waste wood to get raw materials

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "BioFlex" data sheet

The following table provides information about the project.

Coordinator
CHRYSALIX TECHNOLOGIES LIMITED 

Organization address
address: 52 PRINCES GATE
city: LONDON
postcode: SW7 2PG
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.chrysalixtechnologies.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2019-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CHRYSALIX TECHNOLOGIES LIMITED UK (LONDON) coordinator 50˙000.00

Map

 Project objective

We have developed the BioFlex solvent process that uses unwanted waste wood as a very cheap raw-material to produce clean and high-quality inputs for the production of renewable chemicals, fuels and materials. An inexpensive process separates the main components of wood: cellulose and lignin. These can then be turned into final products such as bio-plastics, common chemicals and novel materials. There are a variety of new value chains that are potentially created through our technology. For example, using the waste wood from a local council, cellulose can be isolated, which is hydrolysed, fermented to succinic acid and then used in paint. The lignin isolated alongside the cellulose can be turned into a drop-in biodiesel sold at the local petrol station. Similarly, sawdust from a timber mill can be fractionated, the cellulose used to produce methylcellulose as a thickener in food, the lignin turned into a bio-derived plastic. We are diverting wood waste from going to landfill or incineration and sawdust going into pellets. The European pellets market is saturated, also with pellets imported from the Americas. The lignin and cellulose produced from these currently underused wood resources can enter new, emerging, or existing value chains. Our competition on the waste wood disposal side is incineration, offering energy recovery in some cases but resulting in the formation of toxic ash and contributing to air pollution. For some heavily treated waste wood there are no competitors except for costly and highly undesirable landfilling which are largely viewed as problematic by both waste producers and waste managers. The market is estimated to be EUR 40.9 billion for BioFlex products and EUR 13.4 billion of waste wood recycling. We have established a clear timeline for commercialization and signed a number of agreements with partners to make this plan feasible. We have an interdisciplinary and dedicated team to make Bioflex and its products available on the market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIOFLEX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIOFLEX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Totem Spoon (2019)

Interactive Digital Signage with emotional intelligence for smart cities

Read More  

RDNA (2019)

Empowering New Venture Growth - RDNA

Read More  

MEDIVAC (2019)

Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems

Read More